e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD comorbidity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort
D. Caillaud, P. Carré, R. Escamilla, P. Chanez, P. R. Burgel, G. Jebrak, I. Court-Fortune, G. Brinchault-Rabin, C. Leroyer, F. Lemoigne, N. Roche, and Investigators for the ²Initiatives BPCO² Scientific Committee (Paris, France)
Source:
Annual Congress 2006 - COPD comorbidity
Session:
COPD comorbidity
Session type:
Electronic Poster Discussion
Number:
994
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Caillaud, P. Carré, R. Escamilla, P. Chanez, P. R. Burgel, G. Jebrak, I. Court-Fortune, G. Brinchault-Rabin, C. Leroyer, F. Lemoigne, N. Roche, and Investigators for the ²Initiatives BPCO² Scientific Committee (Paris, France). Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort. Eur Respir J 2006; 28: Suppl. 50, 994
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017
Relationship between lung function disorders and condition of cardiovascular system in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003
Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Changes in cognitive status during acute exacerbation of COPD
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Lung function impairment, COPD hospitalisations and subsequent mortality
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
Cognitive impairment and clinical characteristics in patients with COPD
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR)
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014
An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept